WAC 246-102-010   Definitions.  The definitions in this section apply throughout this chapter unless the context clearly indicates otherwise.

     (1) "Cancer case" means:

     (a) Any malignant or cancerous neoplasm except basal and squamous cell carcinoma of the skin;

     (b) Carcinoma of the external genital organ sites, including those with histology identified as basal or squamous cell type. External genital organ sites include the vulva, labia, clitoris, prepuce, penis and scrotum;

     (c) Neoplasms noted as carcinoma in situ or noninvasive carcinomas, except carcinoma in situ of the cervix uteri;

     (d) All benign, uncertain, borderline or malignant solid intracranial and central nervous system tumors, including the meninges and intracranial endocrine structures;

     (e) All hematopoietic and lymphoid neoplasms including certain potentially malignant hematopoietic conditions;

     (f) Other diagnoses that meet the reporting requirements of:

     (i) The Center for Disease Control's National Program of Cancer Registries;

     (ii) The National Cancer Institute's Surveillance Epidemiology and End Results Program;

     (iii) The North American Association of Central Cancer Registries as described by the International Classification of Disease for Oncology, Third Edition (ICD-O-3);

     (iv) The North American Association of Central Cancer Registries as described by the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition, Volume 2 published by the World Health Organization.

     (2) "Case report" means a complete report, including all items in WAC 246-102-040(3), documenting a cancer case.

     (3) "Certified tumor registrar (CTR)" means an individual certified by the National Cancer Registrars Association.

     (4) "Department" means the Washington state department of health.

     (5) "First course treatment" means all methods of treatment documented in the treatment plan after the original diagnosis and administered to the patient before disease progression or recurrence.

     (6) "Health care facility" means any facility or institution which diagnoses, evaluates, provides treatment to patients or provides biomarker or other required prognostic or predictive information to physicians on patients with reportable or potentially reportable cancer cases. Health care facilities include:

     (a) Hospitals providing either inpatient or outpatient services;

     (b) Free-standing surgical, radiation therapy, imaging, and oncology centers;

     (c) Health maintenance organizations;

     (d) Multispecialty clinics;

     (e) Hospices;

     (f) Ambulatory surgical facilities; and

     (g) Other outpatient facilities.

     (7) "Health care provider" means a person licensed, certified, or registered under RCW 18.130.040 and who diagnoses, evaluates, or provides treatment to patients with reportable or potentially reportable cancer cases.

     (8) "Laboratory" means pathology, cytology, biomarker, molecular, genetic and other clinical or reference laboratories, including both hospital laboratories and free-standing laboratories.

     (9) "Potentially reportable cancer case" means the reporting of a cancer case based on ambiguous terminology.

     (10) "Reporting entity" means any health care facility, laboratory, treatment center, or health care provider.

     (11) "Stage of disease" means how far the cancer has spread from the organ or site of origin at the time of diagnosis and treatment planning.

     (12) "State cancer registry" means the Washington state cancer registry.



[Statutory Authority: RCW 70.54.240 through 70.54.270. 11-20-107, § 246-102-010, filed 10/5/11, effective 11/5/11. Statutory Authority: RCW 70.54.270, 43.20.050, 43.70.130. 01-04-086, § 246-102-010, filed 2/7/01, effective 3/10/01.]